• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Calumet Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    5/9/25 8:40:16 AM ET
    $CLMT
    Integrated oil Companies
    Energy
    Get the next $CLMT alert in real time by email
    Calumet, Inc. /DE0002013745false00020137452025-05-092025-05-09

    ​

    ​

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION

    ​

    Washington, D.C. 20549

    FORM 8-K

    ​

    CURRENT REPORT

    ​

    Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

    ​

    Date of Report (Date of earliest event reported): May 9, 2025

    CALUMET, INC.

    (Exact name of registrant as specified in its charter)

    ​

    Delaware

        

    001-42172

        

    36-5098520

    (State or other jurisdiction of incorporation)

    ​

    (Commission File Number)

    ​

    (IRS Employer Identification No.)

    ​

    1060 N Capitol Ave

    Suite 6-401

    Indianapolis, Indiana 46204

    (Address of principal executive offices) (Zip Code)

    ​

    Registrant’s telephone number, including area code (317) 328-5660

    ​

    (Former name or former address, if changed since last report.)

    ​

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

    ​

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities Registered Pursuant to Section 12(b) of the Act:

    Title of each class

        

    Trading symbol(s)

        

    Name of each exchange on which registered

     

    Common Stock, par value $0.01 per share

    ​

    CLMT

    ​

    The Nasdaq Stock Market LLC

    ​

    ​

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    ​

    Emerging growth company ☐

    ​

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

    ​

    ​

    ​

    ​

    Item 2.02 Results of Operations and Financial Condition.

    On May 9, 2025, Calumet, Inc. reported results of operations for the quarter ended March 31, 2025, pursuant to a press release. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

    In accordance with General Instruction B.2 of Form 8-K, the information contained in this report shall not be deemed “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, nor shall such information and Exhibit be deemed incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference in such filing.

    Item 9.01 Financial Statements and Exhibits.

    (d) Exhibits.

    ​

    Exhibit No.

        

    Description

    99.1

    ​

    Press release dated May 9, 2025.

    104

    ​

    Cover Page Interactive Data File- the cover page XBRL tags are embedded within the Inline XBRL document.

    ​

    ​

    ​

    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    ​

    ​

    ​

    ​

    ​

    ​

    CALUMET, INC.

    ​

    ​

    ​

    ​

    ​

    May 9, 2025

    By:

    /s/ David Lunin

    ​

    ​

    Name: David Lunin

    ​

    ​

    Title: Executive Vice President and Chief Financial Officer

    ​

    ​

    ​

    Get the next $CLMT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CLMT

    DatePrice TargetRatingAnalyst
    5/13/2025$15.00Buy
    BofA Securities
    3/17/2025$15.00 → $12.00Sell → Neutral
    UBS
    3/4/2025$26.00 → $16.00Buy → Hold
    TD Cowen
    2/4/2025$20.50 → $15.00Neutral → Sell
    UBS
    11/11/2024$27.00 → $26.00Buy
    TD Cowen
    10/17/2024$22.00 → $27.00Buy
    TD Cowen
    8/12/2024$20.00 → $18.00Buy
    TD Cowen
    8/18/2022$14.00 → $23.00Neutral → Buy
    Goldman
    More analyst ratings

    $CLMT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • BofA Securities initiated coverage on Calumet Specialty Products with a new price target

      BofA Securities initiated coverage of Calumet Specialty Products with a rating of Buy and set a new price target of $15.00

      5/13/25 9:39:07 AM ET
      $CLMT
      Integrated oil Companies
      Energy
    • Calumet Specialty Products upgraded by UBS with a new price target

      UBS upgraded Calumet Specialty Products from Sell to Neutral and set a new price target of $12.00 from $15.00 previously

      3/17/25 7:29:12 AM ET
      $CLMT
      Integrated oil Companies
      Energy
    • Calumet Specialty Products downgraded by TD Cowen with a new price target

      TD Cowen downgraded Calumet Specialty Products from Buy to Hold and set a new price target of $16.00 from $26.00 previously

      3/4/25 7:20:00 AM ET
      $CLMT
      Integrated oil Companies
      Energy

    $CLMT
    SEC Filings

    See more
    • SEC Form 144 filed by Calumet Inc.

      144 - Calumet, Inc. /DE (0002013745) (Subject)

      6/16/25 4:25:33 PM ET
      $CLMT
      Integrated oil Companies
      Energy
    • SEC Form 144 filed by Calumet Inc.

      144 - Calumet, Inc. /DE (0002013745) (Subject)

      6/16/25 12:48:17 PM ET
      $CLMT
      Integrated oil Companies
      Energy
    • SEC Form 8-K filed by Calumet Inc.

      8-K - Calumet, Inc. /DE (0002013745) (Filer)

      6/16/25 9:16:04 AM ET
      $CLMT
      Integrated oil Companies
      Energy